Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1948 1
1960 1
1961 1
1964 1
1965 2
1966 3
1967 1
1970 2
1971 2
1972 5
1973 2
1975 5
1976 4
1977 4
1978 6
1979 5
1980 5
1981 2
1982 3
1983 4
1984 3
1985 3
1987 3
1988 4
1989 6
1990 5
1991 4
1992 4
1993 7
1994 5
1995 5
1996 10
1997 1
1998 7
1999 5
2000 4
2001 6
2002 5
2003 10
2004 7
2005 8
2006 3
2007 6
2008 3
2009 3
2010 3
2011 7
2012 6
2013 5
2014 8
2015 4
2016 8
2017 8
2018 12
2019 17
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 12042585

262 results
Results by year
Filters applied: . Clear all
Page 1
Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
Nilsson A, De Milito A, Engström P, Nordin M, Narita M, Grillner L, Chiodi F, Björk O. Nilsson A, et al. Pediatrics. 2002 Jun;109(6):e91. doi: 10.1542/peds.109.6.e91. Pediatrics. 2002. PMID: 12042585
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S. Zignol M, et al. Cancer. 2004 Aug 1;101(3):635-41. doi: 10.1002/cncr.20384. Cancer. 2004. PMID: 15274078 Free article.
Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
Volc SM, Almeida MT, Abadi MD, Cornacchioni AL, Odone Filho V, Cristofani LM. Volc SM, et al. J Pediatr (Rio J). 2006 Nov-Dec;82(6):481-4. doi: 10.2223/JPED.1532. Epub 2006 Sep 21. J Pediatr (Rio J). 2006. PMID: 17003944 Free article.
Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer.
Bochennek K, Allwinn R, Langer R, Becker M, Keppler OT, Klingebiel T, Lehrnbecher T. Bochennek K, et al. Vaccine. 2014 Jun 5;32(27):3357-61. doi: 10.1016/j.vaccine.2014.04.042. Epub 2014 Apr 29. Vaccine. 2014. PMID: 24793952
Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL, Castaneda D, Arellano Quintanilla DM, Martínez D, Trumbo SP, Fernández de Castro J. Díaz Ortega JL, et al. Vaccine. 2017 May 25;35(23):3116-3122. doi: 10.1016/j.vaccine.2017.04.027. Epub 2017 Apr 28. Vaccine. 2017. PMID: 28457672
Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
Aytac S, Yalcin SS, Cetin M, Yetgin S, Gumruk F, Tuncer M, Yurdakok K, Gurgey A. Aytac S, et al. Pediatr Hematol Oncol. 2010 Aug;27(5):333-43. doi: 10.3109/08880011003767720. Pediatr Hematol Oncol. 2010. PMID: 20469978
Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P. Knuf M, et al. Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21. Eur J Pediatr. 2012. PMID: 21935584 Clinical Trial.
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M. Kontio M, et al. J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9. J Infect Dis. 2016. PMID: 26908733
Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R, Rahman MM, Hassan Z, Hassan MS. Sultana R, et al. Scand J Immunol. 2006 Dec;64(6):684-9. doi: 10.1111/j.1365-3083.2006.01857.x. Scand J Immunol. 2006. PMID: 17083626 Free article.
262 results
Jump to page
Feedback